For the first time in 15 years, the United States Food and Drug Administration (FDA) has approved a new treatment for mesothelioma.

Mesothelioma is a cancerous disease that primarily affects the cells that line the lungs and peritoneum. Mesothelioma is often attributed to exposure to asbestos fibers through work sites or products containing asbestos. The delayed onset of symptoms, or latency period, can be as long as 20 years after exposure.

If you are diagnosed with mesothelioma, surgery is one of the most standard treatment options.